900120 — CXI Healthcare Technology Balance Sheet
0.000.00%
- KR₩37bn
- -KR₩16bn
- CNY238.58m
Annual balance sheet for CXI Healthcare Technology, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 341 | 522 | 840 | 1,060 | 268 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 174 | 145 | 142 | 97.3 | 79 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 518 | 670 | 983 | 1,158 | 348 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,650 | 1,522 | 1,373 | 1,250 | 2,138 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,220 | 2,298 | 2,541 | 2,612 | 2,718 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 45.3 | 15.4 | 13.5 | 10.5 | 10.3 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 45.9 | 18.6 | 14.3 | 13.4 | 14 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 2,174 | 2,279 | 2,527 | 2,599 | 2,704 |
| Total Liabilities & Shareholders' Equity | 2,220 | 2,298 | 2,541 | 2,612 | 2,718 |
| Total Common Shares Outstanding |